The Global Genetic Testing Market is estimated to grow at CAGR above 11 % over the forecast time frame 2019-2026 and reach the market value around USD 18 billion by 2026 Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1351 The genetic test is a gene study examining a blood sample or a sample of other fluid cells from the genetic material. The study focuses on hereditary and gene variations and numbers of chromosomes which are used to detect genetic disorders and to select specific therapies to treat these genetic disorders. Genetic testing includes several techniques like comparative genomic Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
hybridization, on-site fluorescence, karyotyping, immunohistochemistry and others. Some new genetic testing techniques, increased efficiency and accuracy are expected to provide positive opportunities for global genetic testing. Moreover, in these regions, emerging markets have a good prospect of growing genetic testing because of the growing patient pool and awareness. Some of the main trends in the genetic testing market were the shift from the focus on clinical science to bioinformatics and an increasing popularity in genetic testing technology. Market Snapshots In the future, the worldwide market for genetic testing is expected to record considerable growth as genetic disorder & cancer increases. In the predicted period there are also expected to be increased demand for personalized medicine and the increasing use of genetic testing in oncology to boost market growth. However, the growth of the market of genetic testing during the forecast period is expected to hinder high costs of genetic testing and stringent regulatory requirements for product approvals. Conversely, untapped developing countries ‘ emerging markets are expected to provide market players with compensatory opportunities. Consequently, the global market share for genetic testing is expected to increase these drivers and chances. View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/genetic-testingmarket The market is segmented on a type-based basis into predictive, carrier, prenatal and newborn tests, diagnostic tests, pharmacogenomic and other tests. Currently, the diagnostic test segment leads with revenue in 2018 and its dominance over the projected period is expected to continue. This is Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
because people are increasingly aware of health and the incidence of mortality due to genetic diseases worldwide. On the other hand, during the forecast period the pharmacogenomic test segment is expected to be the highest CAGR. This is largely because pharmaceutical companies are increasingly applying drugs and developing them. Regional Stance The markets in North America, Europe, Asia-Pacific and LAMEA are assessed on the grounds of geography. North America was the global leader in the genetic testing market in 2018 and will dominate the forecasting period. The majority of key players in this region are attributed to this. However, as a result of the increase of accessibility, increased health expenditure and increased attention to early screening of genetic disorders, Asia-Pacific is expected to grow in the highest CAGR over the projected timeframe. In addition, the number of visitors to the cholera-affected countries is rising and the need for immunization is increasing in turn. Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases Key Players & Strategies 23andMe, Abbott Molecular, Biocartis, BioHelix, Bayer Diagnostics, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, HTG Molecular Diagnostics, Luminex, MolecularTM, IntegraGen, LabCorp diagnostics, Myriad, Natera, PacBio, Pathway Geneomaics, Qiagen, Roche Diagnostic is among the most eminent players in the global genetic testing market. Industry players focus on the strategic expansion of their product portfolio through acquisitions, fusions and collaborations. Roche, for example, in December 2018, acquired the Non-invasive Prenatal (NIPT) and cell-free DNA testing services market Ariosa Diagnostics, a provider of molecular diagnostic testing services. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
The increasing prevalence in the genetic testing industry will drive a growing global genetic testing industry for diseases like cancer, cystic fibrosis, Alzheimer’s and others. Increasing genetical tests and genetic mutation identification before their onset will further increase the industry’s growth over the forecast period. Due to the increased adoption of genetic testing by physicians in clinical care, the industry should see rapid growth in future. The availability of direct consumer (DTC) regulatory aid and on-going technological advances allow industry players to maintain a position on the market. Explore Our Market Blog@ https://www.acumenresearchandconsulting.com/blogs TABLE OF CONTENT CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Genetic Testing 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Genetic Testing Market By Type 1.2.2.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Type (2015-2026) 1.2.2.2. Global Genetic Testing Market Revenue Share By Type in 2017 1.2.2.3. Predictive Testing 1.2.2.4. Prenatal & Newborn Testing 1.2.2.5. Diagnostic Testing 1.2.2.6. Carrier Testing 1.2.2.7. Pharmacogenomic Testing Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
1.2.2.8. Others 1.2.3. Genetic Testing Market By Technology 1.2.3.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026) 1.2.3.2. Global Genetic Testing Market Revenue Share By Technology in 2017 1.2.3.3. Biochemical Testing 1.2.3.4. Cytogenetic Testing/ Chromosome Analysis 1.2.3.5. Molecular Testing 1.2.3.6. DNA Sequencing 1.2.3.7. Others 1.2.4. Genetic Testing Market By Application 1.2.4.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Application (2015-2026) 1.2.4.2. Global Genetic Testing Market Revenue Share By Application in 2017 1.2.4.3. Genetic Disease Diagnosis 1.2.4.4. Cardiovascular Disease Diagnosis 1.2.4.5. Chromosome Analysis 1.2.4.6. Others 1.2.5. Genetic Testing Market by Geography 1.2.5.1. Global Genetic Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026) 1.2.5.2. North America Genetic Testing Market Revenue and Growth Rate (2015-2026) 1.2.5.3. Europe Genetic Testing Market Revenue and Growth Rate (20152026) 1.2.5.4. Asia-Pacific Genetic Testing Market Revenue and Growth Rate (20152026) 1.2.5.5. Latin America Genetic Testing Market Revenue and Growth Rate (2015-2026) 1.2.5.6. Middle East and Africa (MEA) Genetic Testing Market Revenue and Growth Rate (2015-2026) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porter’s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2017 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Genetic Testing Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Genetic Testing Major Manufacturers in 2017 3.3. R&D Status and Technology Source of Global Genetic Testing Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Genetic Testing Major Manufacturers in 2017
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
CHAPTER 4. GENETIC TESTING MARKET BY TYPE 4.1. Global Genetic Testing Revenue By Type 4.2. Predictive Testing 4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.3. Prenatal & Newborn Testing 4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.4. Diagnostic Testing 4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.5. Carrier Testing 4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.6. Pharmacogenomic Testing 4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.7. Others 4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 5. GENETIC TESTING MARKET BY TECHNOLOGY 5.1. Global Genetic Testing Revenue By Technology 5.2. Biochemical Testing 5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.3. Cytogenetic Testing/ Chromosome Analysis 5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.4. Molecular Testing Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.5. DNA Sequencing 5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.6. Others 5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 6. GENETIC TESTING MARKET BY APPLICATION 6.1. Global Genetic Testing Revenue By Application 6.2. Genetic Disease Diagnosis 6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.3. Cardiovascular Disease Diagnosis 6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.4. Chromosome Analysis 6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.5. Others 6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 7. NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY 7.1. North America Genetic Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.2. North America Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%) 7.3. U.S. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
7.3.1. U.S. Genetic Testing Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 7.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 7.4. Canada 7.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 7.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 7.5. Mexico 7.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 7.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 8. EUROPE GENETIC TESTING MARKET BY COUNTRY 8.1. Europe Genetic Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million) 8.2. Europe Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%) 8.3. UK 8.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 8.4. Germany 8.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 8.5. France 8.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 8.6. Spain 8.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.6.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 8.7. Rest of Europe 8.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.7.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
CHAPTER 9. ASIA-PACIFIC GENETIC TESTING MARKET BY COUNTRY 9.1. Asia-Pacific Genetic Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million) 9.2. Asia-Pacific Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%) 9.3. China 9.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.4. Japan 9.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.5. India 9.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.6. Australia 9.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.6.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.7. South Korea 9.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.7.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.8. Rest of Asia-Pacific 9.8.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.8.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 10. LATIN AMERICA GENETIC TESTING MARKET BY COUNTRY 10.1. Latin America Genetic Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million) 10.2. Latin America Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%) 10.3. Brazil Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
10.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 10.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 10.4. Argentina 10.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 10.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 10.5. Rest of Latin America 10.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 10.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 11. MIDDLE EAST GENETIC TESTING MARKET BY COUNTRY 11.1. Middle East Genetic Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million) 11.2. Middle East Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%) 11.3. Saudi Arabia 11.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 11.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 11.4. UAE 11.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 11.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 11.5. Rest of Middle East 11.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 11.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 12. AFRICA GENETIC TESTING MARKET BY COUNTRY 12.1. Africa Genetic Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million) 12.2. Africa Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%) 12.3. South Africa Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
12.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 12.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 12.4. Egypt 12.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 12.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 12.5. Rest of Africa 12.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 12.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 13. COMPANY PROFILE 13.1. 23andMe 13.1.1. Company Snapshot 13.1.2. Overview 13.1.3. Financial Overview 13.1.4. Product Portfolio 13.1.5. Key Developments 13.1.6. Strategies 13.2. Abbott Molecular 13.2.1. Company Snapshot 13.2.2. Overview 13.2.3. Financial Overview 13.2.4. Product Portfolio 13.2.5. Key Developments 13.2.6. Strategies 13.3. Biocartis 13.3.1. Company Snapshot 13.3.2. Overview 13.3.3. Financial Overview 13.3.4. Product Portfolio 13.3.5. Key Developments Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
13.3.6. Strategies 13.4. BioHelix 13.4.1. Company Snapshot 13.4.2. Overview 13.4.3. Financial Overview 13.4.4. Product Portfolio 13.4.5. Key Developments 13.4.6. Strategies 13.5. Bayer Diagnostics 13.5.1. Company Snapshot 13.5.2. Overview 13.5.3. Financial Overview 13.5.4. Product Portfolio 13.5.5. Key Developments 13.5.6. Strategies 13.6. BioMerieux 13.6.1. Company Snapshot 13.6.2. Overview 13.6.3. Financial Overview 13.6.4. Product Portfolio 13.6.5. Key Developments 13.6.6. Strategies 13.7. BGI 13.7.1. Company Snapshot 13.7.2. Overview 13.7.3. Financial Overview 13.7.4. Product Portfolio 13.7.5. Key Developments 13.7.6. Strategies 13.8. Celera Genomics 13.8.1. Company Snapshot Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
13.8.2. Overview 13.8.3. Financial Overview 13.8.4. Product Portfolio 13.8.5. Key Developments 13.8.6. Strategies 13.9. Cepheid 13.9.1. Company Snapshot 13.9.2. Overview 13.9.3. Financial Overview 13.9.4. Product Portfolio 13.9.5. Key Developments 13.9.6. Strategies 13.10. Counsyl 13.10.1. Company Snapshot 13.10.2. Overview 13.10.3. Financial Overview 13.10.4. Product Portfolio 13.10.5. Key Developments 13.10.6. Strategies 13.11. deCODEme 13.11.1. Company Snapshot 13.11.2. Overview 13.11.3. Financial Overview 13.11.4. Product Portfolio 13.11.5. Key Developments 13.11.6. Strategies 13.12. Genentech 13.12.1. Company Snapshot 13.12.2. Overview 13.12.3. Financial Overview 13.12.4. Product Portfolio Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
13.12.5. Key Developments 13.12.6. Strategies 13.13. Genomictree 13.13.1. Company Snapshot 13.13.2. Overview 13.13.3. Financial Overview 13.13.4. Product Portfolio 13.13.5. Key Developments 13.13.6. Strategies 13.14. HTG Molecular Diagnostics 13.14.1. Company Snapshot 13.14.2. Overview 13.14.3. Financial Overview 13.14.4. Product Portfolio 13.14.5. Key Developments 13.14.6. Strategies 13.15. Luminex 13.15.1. Company Snapshot 13.15.2. Overview 13.15.3. Financial Overview 13.15.4. Product Portfolio 13.15.5. Key Developments 13.15.6. Strategies 13.16. MolecularMD 13.16.1. Company Snapshot 13.16.2. Overview 13.16.3. Financial Overview 13.16.4. Product Portfolio 13.16.5. Key Developments 13.16.6. Strategies 13.17. IntegraGen Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
13.17.1. Company Snapshot 13.17.2. Overview 13.17.3. Financial Overview 13.17.4. Product Portfolio 13.17.5. Key Developments 13.17.6. Strategies 13.18. LabCorp diagnostics 13.18.1. Company Snapshot 13.18.2. Overview 13.18.3. Financial Overview 13.18.4. Product Portfolio 13.18.5. Key Developments 13.18.6. Strategies 13.19. Myriad 13.19.1. Company Snapshot 13.19.2. Overview 13.19.3. Financial Overview 13.19.4. Product Portfolio 13.19.5. Key Developments 13.19.6. Strategies 13.20. Natera 13.20.1. Company Snapshot 13.20.2. Overview 13.20.3. Financial Overview 13.20.4. Product Portfolio 13.20.5. Key Developments 13.20.6. Strategies 13.21. PacBio 13.21.1. Company Snapshot 13.21.2. Overview 13.21.3. Financial Overview Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
13.21.4. Product Portfolio 13.21.5. Key Developments 13.21.6. Strategies 13.22. Pathway Genomics 13.22.1. Company Snapshot 13.22.2. Overview 13.22.3. Financial Overview 13.22.4. Product Portfolio 13.22.5. Key Developments 13.22.6. Strategies 13.23. Qiagen 13.23.1. Company Snapshot 13.23.2. Overview 13.23.3. Financial Overview 13.23.4. Product Portfolio 13.23.5. Key Developments 13.23.6. Strategies 13.24. Roche Diagnostic 13.24.1. Company Snapshot 13.24.2. Overview 13.24.3. Financial Overview 13.24.4. Product Portfolio 13.24.5. Key Developments 13.24.6. Strategies 13.25. Others 13.25.1. Company Snapshot 13.25.2. Overview 13.25.3. Financial Overview 13.25.4. Product Portfolio 13.25.5. Key Developments 13.25.6. Strategies Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
CHAPTER 14. RESEARCH APPROACH 14.1. Research Methodology 14.1.1. Initial Data Search 14.1.2. Secondary Research 14.1.3. Primary Research 14.2. Assumptions and Scope To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/1351 The report is readily available and can be dispatched immediately after payment confirmation.
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157